EMEA-001957-PIP02-19 - paediatric investigation plan
Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes
PIPHuman
Key facts
- Active Substance
- Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes
- Therapeutic area
- Neurology
- Decision number
- P/0211/2020
- PIP number
- EMEA-001957-PIP02-19
- Pharmaceutical form(s)
- Dispersion for infusion
- Condition(s) / indication(s)
- Treatment of ataxia telangiectasia
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
EryDel S.p.A
E-mail: alyssa.wyant@erydel.com
Tel. +39 0236504470- Decision type
- P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
- Decision date